One issue that probably won't be announced is the TGA approval for CardioCel in Australia. The following is the response I received to my inquiry -
"We are still relying on the process through the TGA here in Australia. At this stage I believe that it will either be later this year or early next year. Again we are relying on the process from a third party."
Probably not a big market anyway.
One issue that probably won't be announced is the TGA approval...
-
- There are more pages in this discussion • 482 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.81 |
Change
-0.190(1.06%) |
Mkt cap ! $342.3M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $42.44K | 2.364K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $17.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.90 | 35 | 3 |
View Market Depth
| Last trade - 13.24pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |